MENU
+Compare
EMBC
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$14.41
Change
-$0.09 (-0.62%)
Capitalization
842.48M

EMBC Embecta Corp Forecast, Technical & Fundamental Analysis

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more

EMBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EMBC with price predictions
Nov 13, 2025

EMBC in upward trend: price rose above 50-day moving average on November 11, 2025

EMBC moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend. In of 24 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on EMBC as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EMBC just turned positive on November 11, 2025. Looking at past instances where EMBC's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMBC advanced for three days, in of 198 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for EMBC crossed bearishly below the 50-day moving average on October 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EMBC entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (10.086). P/E Ratio (10.144) is within average values for comparable stocks, (153.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.600). EMBC has a moderately high Dividend Yield (0.042) as compared to the industry average of (0.016). P/S Ratio (0.768) is also within normal values, averaging (110.982).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EMBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
EMBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EMBC is expected to report earnings to fall 59.28% to 45 cents per share on December 23

Embecta Corp EMBC Stock Earnings Reports
Q3'25
Est.
$0.46
Q2'25
Beat
by $0.35
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.09
The last earnings report on August 08 showed earnings per share of $1.12, beating the estimate of 76 cents. With 303.46K shares outstanding, the current market capitalization sits at 842.48M.
A.I.Advisor
published Dividends

EMBC paid dividends on September 15, 2025

Embecta Corp EMBC Stock Dividends
А dividend of $0.15 per share was paid with a record date of September 15, 2025, and an ex-dividend date of August 29, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
300 Kimball Drive
Phone
+1 862 401-0000
Employees
2200
Web
https://www.embecta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STVYX18.50-0.05
-0.27%
SEI Tax-Managed Mgd Volatility Y (SIMT)
MKVGX17.62-0.06
-0.34%
MFS International Large Cap Value R4
SLESX12.13-0.16
-1.30%
Invesco Income Advantage U.S. Fund R6
CRMEX7.11-0.14
-1.93%
CRM All Cap Value Inv
GGEYX30.09-0.68
-2.21%
GuideStone Funds Growth Equity Instl

EMBC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+1.97%
WAT - EMBC
37%
Loosely correlated
+0.32%
MTD - EMBC
37%
Loosely correlated
+0.19%
AZTA - EMBC
37%
Loosely correlated
+0.36%
RVTY - EMBC
36%
Loosely correlated
-0.19%
A - EMBC
35%
Loosely correlated
+1.41%
More

Groups containing EMBC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+1.97%
Pharmaceuticals
category (378 stocks)
32%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
28%
Poorly correlated
-1.40%